Sickle cell disease trials in Lebanon

4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

  Where

  Beirut, Tripoli

  Age

  6 months to 18 years

  People

  95 worldwide

  Run by

  Forma Therapeutics, Inc.

  See details and how to joinNCT06198712 · EU 2024-519881-32-00
• Phase 3Taking people
  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Where

  Hamra, Hazmiyeh, Tripoli

  Age

  2 years and over

  People

  480 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06609226 · EU 2024-510805-27-00
• Phase 3Taking people
  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  Where

  Hamra, Tripoli

  Age

  12 years and over

  People

  510 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06612268 · EU 2023-509175-16-00
• Phase 4Taking people
  Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  Where

  Beirut, Tripoli

  Age

  6 months to 100 years

  People

  130 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04657822 · EU 2024-510734-41-00